Thus, it is likely that the R268Q mutation in PMCA4, which causes functional impairment in calcium extrusion similar to mutated PMCA2 and PMCA3, plays a role in the pathogenesis of the clinical phenotype of FSP. This evidence concerns the gene ATP2B3 and hereditary spastic paraplegia.